BioAlps - Swiss Health Valley’s Post

[#innaxe4eu] Zoom on insights from the Council of European BioRegions - CEBR! 🛠️ Last month, Council of European BioRegions - CEBR organized interviews and an interactive discussion on “Enhancing the impact of EU life sciences clusters actions through international cooperation” with stakeholders from the health and life science European sector to gather insights and recommendations on INNAXE’s future joint action plan.   📌 Cluster to cluster (C2C) cooperation is pivotal, grounded in mutual trust and involving cluster organizations, their companies, and stakeholders directly. 📌 EU clusters are motivated to collaborate in tackling shared challenges, demonstrating a collective commitment to innovation. 📌 Matching innovators with investors poses a significant challenge across diverse countries and ecosystems, emphasized as a top priority for many clusters. 📌 Real-world needs should inform the development of new products, with public procurement of innovation playing a role in enhancing healthcare quality and equity. 📌 European cooperation prioritizes advanced therapies and health data access, with regulatory and educational aspects taking precedence over technical considerations. Additionally, cascade funding is recognized as a valuable tool to support competitiveness, underscored by the importance of quality support provided by clusters. 🙏 Many thanks to Council of European BioRegions - CEBR BioRegions and the European ecosystem for their shared insights to consolidate our joint action plan. #innaxe4eu #Europe #innovation #health #clusters #lifescience #biotech #medtech Marta González Anaïs Le Corvec Alberto Baldi 

Yesterday at the #NordicFutureHealth2024, Ulrika Morris, PhD presented her work within the Biobank Sweden Cohort Project. In short: Swedish biobank cohorts are a gold mine for medical research, used in some 300-400 publications annually. The key step to access these resources are similar across cohorts and you can find more information at biobanksverige.se. However, there are certain issues that biobank cohorts are battling, such as increased legal complexity of sample and data sharing, precuring long-term funding, and the need to ensure their continued use in research. Suggested changes to national legislation might help to some extent. Could the European Health Data Space (EHDS) be a saviour in part? #NordicFutureHealth2024 #research #cohort #biobanking #EHDS #biobank #PrecisionMedicine #PrecisionHealth Biobank Norway NSHG-PM

Why doesn't scientific research evolve as a solution to problems in Brazil? The answers to this question go through several layers and one of them is the importance of the intersection between the public sector and the private sector in building partnerships in both the development and regulation of processes. Who highlights this is Marina Domenech, CEO of Intrials Clinical Research, founder of SAIL for Health and vice-president of the Brazilian Association of Representative Organizations for Clinical Research (ABRACRO). She also states that having Biotimize and a #CDMO in Brazil means being able to scale research and retain technology within the country, avoiding the diaspora of knowledge to reach full innovation. This is a fundamental step towards strengthening the health ecosystem, allowing Brazil to become increasingly self-sufficient in scientific development and expanding the population's access to quality healthcare. #FromPaperToThePeople is a series of content about the importance of infrastructure for scaling research, allowing it to get off the ground and reach those in need. #Sthorm #FindTheOthers #Biotechnology #Biotimize #People #Research #FutureofHealthCare

🌟 Why BioTrinity 2025 Should Be Your Must-Attend Event! 🌟 With so many life sciences conferences, it can be tough to choose. But here's why BioTrinity in London, 1-2 April should be at the top of your list: 🔹 Organised by OBN – the membership network dedicated to supporting life sciences growth. We’re not-for-profit, and we're committed to delivering real value for you.  🔹 Perfectly sized – not too big, not too small, ensuring a focused environment for genuine connections.  🔹 Cutting-edge innovation – showcasing the latest breakthroughs, while addressing the business and investment challenges you face.  🔹 Seamless partnering – with PartneringONE, book pre-scheduled 1:1 meetings and maximize your networking opportunities.  🔹 Convenient venue & expert support – from location to logistics, we’ve got everything covered, plus our team is always on hand to help! Our delegates love BioTrinity, and here’s why:  💬 “A key event for meaningful discussions with potential partners.”  💬 “The perfect place to meet investors and industry leaders.” 👉 Still not sure? Watch the highlights video here: https://lnkd.in/eu6Xv8Mu and see why BioTrinity 2025 is where you need to be! #BioTrinity2025 #LifeSciencesConference #Partnering #Innovation #Networking #Biotech #Healthcare

🚀 Elevate Your Brand at BIO Europe 🌍 Are you ready to showcase your innovation to the world? 📈 The BIO Europe conference is a great stage for life science leaders, and One Nucleus is preparing the ON Helix Review for release at the conference. This could be the spotlight your company needs to shine brighter at BIO Europe and beyond. Prices start at just £500 + VAT for One Nucleus members. Why Sponsor the ON Helix Review? ✨ Unparalleled Visibility: Reach thousands of top-tier professionals and decision-makers in the international life sciences. ✨ Targeted Audience: Connect directly with your ideal customers, investors, and partners. ✨ Premium Placement: Stand out in a comprehensive review that attendees trust and reference. 📅 Don’t miss this golden opportunity to amplify your brand’s impact at one of the most influential events of the year. Secure your ad space now and be part of the conversation driving the future of life sciences. 🌟 Join us in transforming the future of life sciences and biotechnology. Your innovation deserves the spotlight! 🔗 Find out more here https://lnkd.in/eJ-TwrdB #BIOEurope #LifeSciences #Biotech #Innovation #Healthcare #BusinessGrowth #Marketing #Conference2024

❗ European Helicobacter and Microbiota Study group (EHMSG) is a TOGAS partner with the responsibility of organizing the annual September stakeholder outreach conferences. January, 2024 the Board of EHMSG together with the scientific coordinator of the project M.Leja have been meeting in Porto, 🇵🇹 to plan the upcoming meeting in 2024. It was decided to have the meeting September 12, 2024 in Porto 🇵🇹 The potential conference sessions and speakers were discussed. The group evaluated the previous 2023 conference in Antwerp 🇧🇪 as s success. ○      @European Health and Digital Executive Agency @togas-eu-project #HealthUnion #EU4Health #EUCancerPlan

Why doesn’t scientific research evolve as a solution to problems in Brazil? This answer even has a famous term among researchers: The Valley of Death - a limbo where scientific research in the health area stagnates and does not advance to reach the clinical testing phases. The person who explains this is Cristiano Gonçalves, Director of Innovation and Technological Licensing at Instituto Butantan. Given this scenario, Cristiano mentions the importance of the role of Biotimize, a startup in the Sthorm health hub, which recently opened a pioneering development complex operating in the “as a service” model (CDMO) under conditions of Good Laboratory Practices ( BPL), this means building a bridge over this valley so that research can develop within the country and reach the pre-clinical phase. #FromPaperToThePeople is a series of content about the importance of infrastructure for scaling research, allowing it to get off the ground and reach those in need. #Sthorm #FindTheOthers #Biotechnology #Biotimize #HeathcareSystem

I'm looking forward to putting important questions to the experts at #BIOEurope in #Stockholm on November 4 and 5: How do we strengthen Europe's venture eco-system - is it only about dressing up more appropriately for US investors? That discussion, under "Money, Money, Money," happens on Monday 4 with Lars Gredsted, Laura A. Lane, Karl Nägler, Medicxi's Nick Williams and Marten Steen Tuesday 5th afternoon brings a red-hot duo: Antibody drug conjugates (ADCs) at 14h and radioligand therapies (RLTs) at 15h. ADCs: where's the latest wave of innovation? Could this category - forecast to reach over $50 billion by 2030 - one day replace chemo? Or are we over-heating? I will ask Merck & Co. Inc.'s Khatereh Ahmadi, Adcendo's Michael Pehl, J&J's Sonal Patel, PhD and Merck KGaA's Gregor Fachinger. RLTs: as they continue to build momentum, where's the most promising action? Is all the noise around isotopes distracting us from the real innovation? Novartis' Marcel R., Debiopharm's Anja Bitterwolf, Ariceum's Serge SAGODIRA and ARTBIO's Emanuele Ostuni will join me to discuss/argue! I hope you can bring one of many excellent audience questions. Here's the agenda: https://lnkd.in/gsqZBDGt

ENCAP4HEALTH is back. This time we are willing to share with all of you in this webinar our main results in the application of membrane emulsification to produce microcapsules. Just register and join us! Thanks a lot to André Brodkorb and Marijana Dragosavac, PhD for organizing. #H2020 #RISE #ENCAPSULATION.

Canada has developed a #biomanufacturing and life sciences strategy which aims to strengthen Canada’s ability to promote a competitive, innovative, and sustainable life sciences and biomanufacturing sector as well as to respond to pandemics and future health emergencies. To do just that, the Government of Canada is dedicating $2.2 billion over seven years.   We are looking forward to the Swiss Biotech Day to continue building strong partnerships and collaboration between Canadian businesses and the Swiss biotech ecosystem. 🤝   Swiss Biotech Association Trade Commissioner Service | Service des délégués commerciaux BIOTECanada Innovation, Science and Economic Development Canada